Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (332) ReoPro, Centocor,
...ReoPro Company: Centocor Approval Status: Approved November 1997 Treatment Area: cardiac ischemia General Information ReoPro (abciximab) has been approved as an adjunctive therapy to prevent cardiac ischemic complications (PCI), as well ...
View Page

2.  Study Posting (1918) Trial #160135, Metastatic Cancer, Savannah, GA
...following*: • Anticoagulants (e.g., tirofiban, eptifibatide, ticlopidine) • Aspirin or aspirin-containing combinations • Epoprostenol • Clopidogrel • Cilostazol • Abciximab NOTE: *Nonsteroidal anti-inflammatory drugs and medically indicated platelet-inhibiting medication allowed • At least 7 ...
View Page

3.  Study Posting (1918) Trial #160134, Breast Cancer, Savannah, GA
...following*: • Anticoagulants (e.g., tirofiban, eptifibatide, ticlopidine) • Aspirin or aspirin-containing combinations • Epoprostenol • Clopidogrel • Cilostazol • Abciximab NOTE: *Nonsteroidal anti-inflammatory drugs and medically indicated platelet-inhibiting medication allowed • At least 7 ...
View Page

4.  Newly Approved Drug Therapies (659) Angiomax (bivalirudin), The Medicines Company,
...interaction studies have been conducted with the ADP antagonist, ticlopidine, and the GPIIb/IIIa inhibitor, abciximab, and with low molecular weight heparin. Although data are limited, thus precluding conclusions regarding efficacy ...
View Page